Featured Story

New vaccine could guard against common birth defect-causing virus

An experimental vaccine using a novel defense mechanism could eventually help treat sufferers of a common virus that affects more than half of the U.S. population and causes congenital birth defects in some cases.

High protein levels linked to cell death in Parkinson's

Researchers may have discovered how a genetic mechanism in a common cause of Parkinson's works to destroy brain cells in patients--a finding that could help scientists develop new therapies for the devastating disease.

UCSF rolls out patient database to boost brain research

Researchers at the University of California, San Francisco, have launched a new online database to help reduce the time and cost of conducting clinical trials for brain ailments.

Essential immune organ regenerated in mice

Scottish scientists report that they have successfully regenerated a living mouse organ and transplanted it into a young mouse.

Study: Fewer clinical trials, less animal research conducted on diseases of the poor

An analysis of nearly 4 million scientific articles has found that drug and disease research is disproportionately focused on medical conditions that predominantly afflict wealthy nations--such as diabetes, cancer and skin diseases--while less attention is given to diseases of the developing countries.


From Our Sister Sites


The FDA has lifted a clinical hold placed on a study at Memorial Sloan-Kettering of Juno Therapeutics' cutting-edge approach to treating cancer using genetically tailored T cells, FierceBiotech has learned.


Drugmakers received the first slice of FDA social media guidance in January, and now the FDA's mailbag is filling up with letters on First Amendment protections, "jurisdictional creep" and other topics from the likes of Pfizer and PhRMA.